These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7361772)

  • 1. Kinetic model for intravenous heparin infusion.
    Bauwens S; Dukes GE
    Am J Hosp Pharm; 1980 Jan; 37(1):26, 31, 37 passim. PubMed ID: 7361772
    [No Abstract]   [Full Text] [Related]  

  • 2. Animal model for pharmacokinetic approach to individualized heparin dosage regimen for i.v. infusion by constant rate to achieve and maintain a desired clotting time.
    Ritschel WA; Brady ME
    Arzneimittelforschung; 1979; 29(12):1891-4. PubMed ID: 546429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of various doses and various applications of heparin on the fat metabolism and on blood coagulation.
    Losonczy H; Nagy I
    Wien Klin Wochenschr; 1984 Dec; 96(24):885-9. PubMed ID: 6528619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fate of heparin in the body.
    Estes JW
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 Pt1):45-57. PubMed ID: 808390
    [No Abstract]   [Full Text] [Related]  

  • 5. [Concerning the article "Problem of heparin dosage" by G. Mombelli].
    Krahenbuhl B
    Schweiz Med Wochenschr; 1984 Aug; 114(31-32):1102-3. PubMed ID: 6494861
    [No Abstract]   [Full Text] [Related]  

  • 6. [The coagulation parameters in high-dosage intravenous heparin therapy].
    Weidmann B
    Dtsch Med Wochenschr; 1994 Mar; 119(12):442. PubMed ID: 8143564
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in blood coagulation during infusion of intralipid.
    Reid DJ; Ingram GI
    Clin Sci; 1967 Oct; 33(2):399-407. PubMed ID: 6058437
    [No Abstract]   [Full Text] [Related]  

  • 8. [Correction of disorders of hemostasis in children with suppurative-infectious diseases].
    Dmitriev VV; Vakul'chik VG
    Khirurgiia (Mosk); 1984 Jul; (7):89-92. PubMed ID: 6482227
    [No Abstract]   [Full Text] [Related]  

  • 9. Heparin administration by constant infusion pump.
    Handley AJ
    Br Med J; 1967 May; 2(5550):482-4. PubMed ID: 6023967
    [No Abstract]   [Full Text] [Related]  

  • 10. The design and initial testing of an implantable infusion pump.
    Blackshear PJ; Dorman FD; Blackshear PL; Varco RL; Buchwald H
    Surg Gynecol Obstet; 1972 Jan; 134(1):51-6. PubMed ID: 5007175
    [No Abstract]   [Full Text] [Related]  

  • 11. Heparin therapy by continuous intravenous infusion.
    Swanson M; Cacace L
    Am J Hosp Pharm; 1971 Oct; 28(10):792-5. PubMed ID: 5125174
    [No Abstract]   [Full Text] [Related]  

  • 12. Kinetics of heparin administration.
    Perry MO; Horton J
    Arch Surg; 1976 Apr; 111(4):403-9. PubMed ID: 1259578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin therapy by continuous intravenous infusion.
    Cacace L; Swanson M
    Am J Hosp Pharm; 1972 Apr; 29(4):294. PubMed ID: 5025255
    [No Abstract]   [Full Text] [Related]  

  • 15. Heparin therapy by continuous intravenous infusion.
    Ashby DM
    Am J Hosp Pharm; 1972 Apr; 29(4):293. PubMed ID: 5025254
    [No Abstract]   [Full Text] [Related]  

  • 16. Fat infusions and blood coagulation. Effect of various fat emulsions on blood coagulability. A comparative study.
    Brockner J; Amris CJ; Larsen V
    Acta Chir Scand Suppl; 1965; 343():48-55. PubMed ID: 5214023
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-thrombotic effects of CX-397, a recombinant hirudin analog, in a canine model of coronary artery thrombosis.
    Ohyama T; Hori T; Moriike M; Asano T; Hayashi H; Iwade K; Hosoda S
    Thromb Haemost; 1998 Feb; 79(2):423-30. PubMed ID: 9493602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An improved method for the intravenous administration of heparin; its clinical application.
    WESSLER S; FISCHBEIN JW
    N Engl J Med; 1954 May; 250(20):860-3. PubMed ID: 13165912
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of the nerve growth factor on blood coagulation and fibrinolysis].
    Isanbaev ChI; Vypova NL; Kazantseva DS; Sagdiev N
    Eksp Klin Farmakol; 1997; 60(3):45-7. PubMed ID: 9324398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heparin. Mode of action, indications, administration].
    Kierulf P
    Tidsskr Nor Laegeforen; 1971 Oct; 91(29):2105-8. PubMed ID: 5130881
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.